Christopher Gabrieli Net Worth

What's Christopher Gabrieli's mailing address?

Christopher's mailing address filed with the SEC is C/O AKCEA THERAPEUTICS, INC., 22 BOSTON WHARF ROAD, 9TH FLOOR, BOSTON, MA, 02210.

Insiders trading at Akcea Therapeutics Inc

Over the last 7 years, insiders at Akcea Therapeutics Inc have traded over $384,023 worth of Akcea Therapeutics Inc stock and bought 35,029,381 units worth $610,464,515 . The most active insiders traders include Pharmaceuticals Inc Ionis, Paula Soteropoulos és B Lynne Parshall. On average, Akcea Therapeutics Inc executives and independent directors trade stock every 69 days with the average trade being worth of $40,228,816. The most recent stock trade was executed by Pharmaceuticals Inc Ionis on 10 October 2020, trading 21,237,715 units of AKCA stock currently worth $385,464,527.

What does Akcea Therapeutics Inc do?

Akcea Therapeutics Inc executives and stock owners

Akcea Therapeutics Inc executives and other stock owners filed with the SEC include:

• Barbara Yanni,
  Director
• Amber Salzman,
  Director
• Joseph Iii Klein,
  Director
• Michael J. Yang,
  Director
• Pharmaceuticals Inc Ionis,
  10% owner
• Michael F Mac Lean,
  Chief Financial Officer
• Jeff Marc Goldberg,
  Chief Operating Officer
• Louis O'dea,
  Chief Medical Officer
• Paula Soteropoulos,
  Chief Executive Officer
• Elaine Hochberg,
  Director
• Edward M Fitzgerald,
  Director
• Sandford D Smith,
  Director
• Richard A Moscicki,
  Director
• Sarah Boyce,
  President
• Christopher Gabrieli,
  Director
• Alex G. Howarth,
  Chief Operating Officer
• B Lynne Parshall,
  Director
• Kyle Jenne,
  Chief Commercial Officer
• Michael Dennis Price,
  Chief Financial Officer
• Damien Mc Devitt,
  Chief Executive Officer
• Joshua F. Patterson,
  General Counsel
• William T. Andrews,
  Chief Medical Officer